Mehmet Kayrak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Kayrak has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abduzhappar Gaipov
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
1 shared publication - Adrian Covic
Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iași, Romania
1 shared publication - Aysun Toker
Department of Biochemistry, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
1 shared publication - Enes Elvin Gul
Department of Cardiology, School of Medicine, Necmettin Erbakan University, Konya, Turkey
1 shared publication - Fatih Mehmet Erdur
Faculty of Medicine, Department of Nephrology, Gaziantep University, Gaziantep, Turkey
1 shared publication - Halil Zeki Tonbul
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey
1 shared publication
Latest Publications
- Open Access
- 12 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 144
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients
Cardiovascular risk is increased in the early stages of chronic kidney disease (CKD) and also found to be ongoing in renal transplant (Rtx) patients. As a sign of atherosclerosis, increased carotid intima-media thickness (CIMT) has been widely accepted as a strong predictor of cardiovascular disease (CVD) and mortality in CKD patients. A novel markers, soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and neutrophil-to-lymphocyte ratio (NLR) were introduced as potential markers in inflammatory disorders including CKD. The role of Rtx in terms of atherogenesis is still unclear. We aimed to investigate the relationship between sTWEAK, NLR and CIMT in Rtx patients without overt CVD and to compare these results with those obtained from healthy subjects. Cross-sectional analysis in which CIMT measurements, NLR and serum TWEAK levels were assessed in 70 Rtx patients (29 females; mean age, 40.6 ± 12.4 years) and 25 healthy subjects (13 females, mean age; 37.4±8.8 years). sTWEAK levels were significantly decreased (p=0.01) and hs-CRP, NLR and CIMT levels of Rtx patients were significantly increased compared to healthy subjects (p<0.0001, p=0.001, p<0.0001, respectively). sTWEAK was also found to be decreased when eGFR was decreased (p=0.04 between all groups). CIMT was positively correlated with sTWEAK and NLR in Rtx patients (r=0.81, p<0.0001 and r=0.33, p=0.006, respectively). sTWEAK was also positively correlated with NLR (r=0.37, p=0.002). In the multivariate analysis only sTWEAK was found to be an independent variable of increased CIMT. sTWEAK might have a role in the pathogenesis of ongoing atherosclerosis in Rtx patients.
- 12 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 144
Open AccessSoluble TWEAK independently predicts atherosclerosis in renal transplant patients
Cardiovascular risk is increased in the early stages of chronic kidney disease (CKD) and also found to be ongoing in renal transplant (Rtx) patients. As a sign of atherosclerosis, increased carotid intima-media thickness (CIMT) has been widely accepted as a strong predictor of cardiovascular disease (CVD) and mortality in CKD patients. A novel markers, soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and neutrophil-to-lymphocyte ratio (NLR) were introduced as potential markers in inflammatory disorders including CKD. The role of Rtx in terms of atherogenesis is still unclear. We aimed to investigate the relationship between sTWEAK, NLR and CIMT in Rtx patients without overt CVD and to compare these results with those obtained from healthy subjects. Cross-sectional analysis in which CIMT measurements, NLR and serum TWEAK levels were assessed in 70 Rtx patients (29 females; mean age, 40.6 ± 12.4 years) and 25 healthy subjects (13 females, mean age; 37.4±8.8 years). sTWEAK levels were significantly decreased (p=0.01) and hs-CRP, NLR and CIMT levels of Rtx patients were significantly increased compared to healthy subjects (p<0.0001, p=0.001, p<0.0001, respectively). sTWEAK was also found to be decreased when eGFR was decreased (p=0.04 between all groups). CIMT was positively correlated with sTWEAK and NLR in Rtx patients (r=0.81, p<0.0001 and r=0.33, p=0.006, respectively). sTWEAK was also positively correlated with NLR (r=0.37, p=0.002). In the multivariate analysis only sTWEAK was found to be an independent variable of increased CIMT. sTWEAK might have a role in the pathogenesis of ongoing atherosclerosis in Rtx patients.